title: Commentary regarding: Efficacy of an Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults. H Lal, AL Cunningham, O Godeaux et al., N Engl J Med 372:2087-2096, 2015.
authors.affiliation: Department of Dermatology, University of Texas Southwestern Medical Center, Dallas, Texas, USA. kim.yancey@utsouthwestern.edu.
authors.forename: Kim B
authors.initials: KB
authors.lastname: Yancey
mesh_terms: D000367:Age Factors; D000368:Aged; D000375:Aging / Q000276:immunology*; D006562:Herpes Zoster / Q000276:immunology / Q000517:prevention & control* / Q000821:virology; D053061:Herpes Zoster Vaccine / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D007273:Injections, Intramuscular; D008875:Middle Aged; D016032:Randomized Controlled Trials as Topic; D016896:Treatment Outcome; D022223:Vaccines, Subunit / Q000627:therapeutic use
chemical_list: D053061:Herpes Zoster Vaccine; D022223:Vaccines, Subunit
keywords: clinical trial; herpes zoster; vaccine